Are you Dr. Sherman?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 37 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
Bipar Science, Inc.
1000 Marina Blvd., Suite 550
Brisbane, CA 94005Phone+1 650-635-6053Fax+1 650-653-6057
Summary
- Dr. Barry Sherman, MD is an endocrinologist in Brisbane, California. He is currently licensed to practice medicine in California.
Education & Training
University of MichiganResidency, Internal Medicine, 1970 - 1971
Jacobi Medical Center/Albert Einstein College of MedicineResidency, Internal Medicine, 1966 - 1968
University of Michigan Medical SchoolClass of 1966
Certifications & Licensure
CA State Medical License 1986 - 2023- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Publications & Presentations
PubMed
- 198 citationsUpregulation of Poly (ADP-Ribose) Polymerase-1 (PARP1) in Triple-Negative Breast Cancer and Other Primary Human Tumor TypesOssovskaya Valeria S, Ingrid Chou Koo, Eric P. Kaldjian, Christopher Alvares, Barry M. Sherman
Genes & Cancer. 2010-08-01 - 588 citationsIniparib plus Chemotherapy in Metastatic Triple-Negative Breast CancerJoyce A. O'Shaughnessy, Cynthia Osborne, John Pippen, Mark Yoffe, Debra A. Patt
The New England Journal of Medicine. 2011-01-19 - 31 citationsOral Poly(ADP-Ribose) Polymerase-1 Inhibitor BSI-401 Has Antitumor Activity and Synergizes with Oxaliplatin against Pancreatic Cancer, Preventing Acute NeurotoxicityDavide Melisi, Ossovskaya Valeria S, Cihui Zhu, Roberta De Rosa, Jianhua Ling
Clinical Cancer Research. 2009-10-15
Press Mentions
Cooley's Anemia Foundation to Honor Scientists for Role in Breakthrough DrugJune 8th, 2017
